Terms: = Liver cancer AND TPR, P12270, 7175 AND Treatment
6 results:
1. Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling.
Yuan K; Lan J; Xu L; Feng X; Liao H; Xie K; Wu H; Zeng Y
Mol Cancer; 2022 Apr; 21(1):105. PubMed ID: 35477447
[TBL] [Abstract] [Full Text] [Related]
2. Identification of personalized dysregulated pathways in hepatocellular carcinoma.
Li H; Jiang X; Zhu S; Sui L
Pathol Res Pract; 2017 Apr; 213(4):327-332. PubMed ID: 28215647
[TBL] [Abstract] [Full Text] [Related]
3. [Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients].
Buti M; Gros B; Oyagüez I; Andrade RJ; Serra MA; Turnes J; Casado MA
Farm Hosp; 2014 Sep; 38(5):418-29. PubMed ID: 25344136
[TBL] [Abstract] [Full Text] [Related]
4. Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands.
Vellopoulou A; van Agthoven M; van der Kolk A; de Knegt RJ; Berdeaux G; Cure S; Bianic F; Lamotte M
Appl Health Econ Health Policy; 2014 Dec; 12(6):647-59. PubMed ID: 25103219
[TBL] [Abstract] [Full Text] [Related]
5. Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease.
Nabhan C; Rundhaugen L; Jatoi M; Riley MB; Boehlke L; Peterson LC; Tallman MS
Ann Oncol; 2004 Aug; 15(8):1231-6. PubMed ID: 15277263
[TBL] [Abstract] [Full Text] [Related]
6. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Ma Q; Whitlock JP
J Biol Chem; 1997 Apr; 272(14):8878-84. PubMed ID: 9083006
[TBL] [Abstract] [Full Text] [Related]
